---
title: "Salubris: Ennalapril (Enalapril Tablets) new indication approved for drug registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256121329.md"
description: "According to the Zhitong Finance APP, Salubris announced that the company has received the drug registration certificate for Enarodustat (Enaro®) approved by the National Medical Products Administration, which is approved for the treatment of anemia in patients with chronic kidney disease (CKD) undergoing dialysis (including hemodialysis and peritoneal dialysis)"
datetime: "2025-09-05T11:27:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256121329.md)
  - [en](https://longbridge.com/en/news/256121329.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256121329.md)
generator: "portal-rs"
---

# Salubris: Ennalapril (Enalapril Tablets) new indication approved for drug registration certificate

According to the Zhitong Finance APP, Salubris (002294.SZ) announced that the company has received the drug registration certificate for Enarodustat (Enaro®) approved by the National Medical Products Administration, which is approved for the treatment of anemia in patients with chronic kidney disease (CKD) undergoing dialysis (including hemodialysis and peritoneal dialysis)

### Related Stocks

- [002294.CN](https://longbridge.com/en/quote/002294.CN.md)

## Related News & Research

- [Vishnusurya Projects and Infra's (NSE:VISHNUINFR) Weak Earnings May Only Reveal A Part Of The Whole Picture](https://longbridge.com/en/news/305559929.md)
- [Pondy Oxides And Chemicals Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected](https://longbridge.com/en/news/305560101.md)
- [Alkem Laboratories Limited (NSE:ALKEM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates](https://longbridge.com/en/news/305559747.md)
- [RioCan Real Estate Investment Trust (TSX:REI.UN) Expands Its Buyback Program, Is It Still Undervalued?](https://longbridge.com/en/news/305557624.md)
- [Kava Lend loses roughly $3.8 million to hack, sending KAVA token down nearly 40%](https://longbridge.com/en/news/305556359.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**